ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 682

$1.25M Total Retail Price of All Prescriptions

Rank: 54 out of 682

437 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

29% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 19,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
FUROSEMIDE 1,007 886 1 7
HYDROCODONE-ACETAMINOPHEN 776 490 S3 2 1
SIMVASTATIN 749 597 3 4
WARFARIN SODIUM 694 614 4 13
OMEPRAZOLE 686 549 5 5
LISINOPRIL 628 507 6 2
LEVOTHYROXINE SODIUM 496 451 7 3
METOPROLOL TARTRATE 490 413 8 10
KLOR-CON M20 461 386 9 67
OXYCODONE-ACETAMINOPHEN 447 360 S2 10 120
AMLODIPINE BESYLATE 438 357 11 6
SERTRALINE HCL 367 318 12 24
NOVOLOG 361 318 13 129
DONEPEZIL HCL 356 348 14 30
GABAPENTIN 305 231 15 9
IPRATROPIUM-ALBUTEROL 295 271 16 139
LANTUS 276 234 17 55
NAMENDA 275 261 18 41
CITALOPRAM HBR 258 210 19 17
RISPERIDONE 246 219 20 82
POTASSIUM CHLORIDE 239 184 21 14
CYMBALTA 238 180 22 51
METFORMIN HCL 233 155 23 8
TRAMADOL HCL 226 165 24 26
PANTOPRAZOLE SODIUM 221 176 25 29
QUETIAPINE FUMARATE 220 186 26 87
OXYBUTYNIN CHLORIDE ER 203 174 27 180
MIRTAZAPINE 202 168 28 52
ALLOPURINOL 189 144 29 32
CARBIDOPA-LEVODOPA 186 178 30 121
FAMOTIDINE 185 162 31 99
CARVEDILOL 182 173 32 23
PROMETHAZINE HCL 180 150 R 33 54
GLIMEPIRIDE 178 128 34 43
PREDNISONE 170 147 35 40
LIDODERM 170 152 35 134
ROPINIROLE HCL 166 162 37 71
CIPROFLOXACIN HCL 162 128 38 58
ATORVASTATIN CALCIUM 160 141 39 11
LEVETIRACETAM 160 107 39 125
POLYETHYLENE GLYCOL 3350 154 134 41 44
FENTANYL 154 87 S2 41 86
TORSEMIDE 150 127 43 155
ZOLPIDEM TARTRATE 141 68 44 21
ATENOLOL 141 138 44 18
EXELON 138 128 46 104
DIVALPROEX SODIUM 137 88 47 84
HYDROCHLOROTHIAZIDE 132 93 48 12
BUSPIRONE HCL 132 105 48 102
TAMSULOSIN HCL 121 96 50 33
DILTIAZEM 24HR CD 120 98 51 123
CEPHALEXIN 119 86 52 128
SULFAMETHOXAZOLE-TRIMETHOPRIM 114 88 53 103
BACLOFEN 112 57 54 130
DIGOXIN 112 110 54 46
CLONIDINE HCL 112 82 54 48
OXYCODONE HCL 107 65 S2 57 93
METOPROLOL SUCCINATE 105 90 58 16
AMOX TR-POTASSIUM CLAVULANATE 105 69 58 110
ONDANSETRON HCL 105 96 58 195
SPIRONOLACTONE 105 104 58 64
HYDRALAZINE HCL 103 61 62 74
DICYCLOMINE HCL 96 48 63 214
LIDOCAINE HCL 94 56 64 266
METOCLOPRAMIDE HCL 94 51 64 111
AZITHROMYCIN 93 64 66 39
ESCITALOPRAM OXALATE 93 61 66 73
OXYCONTIN 88 65 S2 68 178
SEROQUEL 88 67 68 193
LYRICA 85 48 70 78
DICLOFENAC SODIUM 85 56 70 107
CLOPIDOGREL 84 67 72 25
TRAZODONE HCL 84 51 72 38
ISOSORBIDE MONONITRATE ER 81 68 74 31
DILTIAZEM HCL 81 66 74 217
AVELOX 80 68 76 314
MORPHINE SULFATE ER 80 80 S2 76 143
AMIODARONE HCL 78 77 78 170
KLOR-CON M10 78 72 78 186
SPIRIVA 77 56 80 49
DOXYCYCLINE HYCLATE 76 50 81 137
FINASTERIDE 75 52 82 131
GLIPIZIDE 75 74 82 61
PROAIR HFA 74 23 84 45
ALBUTEROL SULFATE 73 73 85 156
JANUVIA 73 72 85 62
METRONIDAZOLE 73 33 85 254
CEFUROXIME 72 68 88 164
CARBAMAZEPINE 71 60 89 251
LOSARTAN POTASSIUM 71 71 89 20
PRIMIDONE 70 32 91 228
OXYCODONE HCL-ACETAMINOPHEN 70 42 S2 91 98
PLAVIX 69 59 93 35
MELOXICAM 68 58 94 27
LOPERAMIDE 68 51 94 253
NITROFURANTOIN MONO-MACRO 68 55 94 204
CHOLESTYRAMINE 62 55 97 366
ACTOS 60 58 98 151
VANCOMYCIN HCL 60 46 98 300
FENOFIBRATE 59 52 100 76
LATANOPROST 59 56 100 277
RANITIDINE HCL 58 34 102 28
ALENDRONATE SODIUM 57 38 103 37
AMPICILLIN TRIHYDRATE 57 52 103 371
OLANZAPINE 57 46 103 168
VALPROIC ACID 56 56 106 262
PHENYTOIN SODIUM EXTENDED 56 24 106 140
FLUCONAZOLE 56 36 106 154
INVANZ 55 50 109 375
PERPHENAZINE 55 49 109 451
FLUOXETINE HCL 55 28 109 60
HYDROCORTISONE 53 44 112 267
PAROXETINE HCL 52 45 113 53
LACTULOSE 52 43 113 100
NEXIUM 51 0 115 19
BRIMONIDINE TARTRATE 50 50 116 371
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.